they need $ 300 K to do the pharmokinetic studies on health volunteers before redoing the PTSD trial. You do wonder why this was not done prior to the last PTSD trial . There will likely be a small bounce in the sp from here as we go into July. But if this is coming back it is going to be a long wait .
- Forums
- ASX - By Stock
- BNO
- Ann: Results of BNC210 Agitation Trial
Ann: Results of BNC210 Agitation Trial, page-40
Featured News
Add BNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online